94 related articles for article (PubMed ID: 25894372)
1. Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer.
Sun R; Liu Z; Wang L; Lv W; Liu J; Ding C; Yuan Y; Lei G; Xu C
Tumour Biol; 2015 Sep; 36(9):7195-204. PubMed ID: 25894372
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles in mouse embryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motility.
Ringhoff DN; Cassimeris L
BMC Genomics; 2009 Jul; 10():343. PubMed ID: 19643027
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
Kubota K; Sakai H; Katakami N; Nishio M; Inoue A; Okamoto H; Isobe H; Kunitoh H; Takiguchi Y; Kobayashi K; Nakamura Y; Ohmatsu H; Sugawara S; Minato K; Fukuda M; Yokoyama A; Takeuchi M; Michimae H; Gemma A; Kudoh S;
Ann Oncol; 2015 Jul; 26(7):1401-8. PubMed ID: 25908605
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors.
Diamond JR; Wu B; Agarwal N; Bowles DW; Lam ET; Werner TL; Rasmussen E; Gamelin E; Soto F; Friberg G; Sun YN; Sharma S
Invest New Drugs; 2015 Jun; 33(3):691-9. PubMed ID: 25895965
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations.
Yokoyama Y; Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Date H
Int J Clin Oncol; 2015 Dec; 20(6):1122-9. PubMed ID: 25953679
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer.
Bondarenko IM; Ingrosso A; Bycott P; Kim S; Cebotaru CL
BMC Cancer; 2015 May; 15():339. PubMed ID: 25929582
[TBL] [Abstract][Full Text] [Related]
7. Investigation of prognostic factors affecting efficacy in carboplatin- and paclitaxel-based first-line chemotherapies for advanced non-small-cell lung cancer.
Komuro M; Kaneko M; Narukawa M
Tumori; 2015; 101(4):424-32. PubMed ID: 25908047
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.
Choi MK; Hong JY; Chang WJ; Kim MJ; Kim SM; Jung HA; Do IG; Choi YL; Sun JM; Ahn JS; Park K; Ahn MJ
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1229-36. PubMed ID: 25903122
[TBL] [Abstract][Full Text] [Related]
9. Resection of oligometastatic lung cancer to the pancreas may yield a survival benefit in select patients--a systematic review.
DeLuzio MR; Moores C; Dhamija A; Wang Z; Cha C; Boffa DJ; Detterbeck FC; Kim AW
Pancreatology; 2015; 15(5):456-462. PubMed ID: 25900320
[TBL] [Abstract][Full Text] [Related]
10. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
[TBL] [Abstract][Full Text] [Related]
11. CSF Concentration of Crizotinib in Two ALK-Positive Non-Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment.
Metro G; Lunardi G; Floridi P; Pascali JP; Marcomigni L; Chiari R; Ludovini V; Crinò L; Gori S
J Thorac Oncol; 2015 May; 10(5):e26-e27. PubMed ID: 25898960
[No Abstract] [Full Text] [Related]
12. Coexistence of P190 and P210 BCR/ABL transcripts in chronic myeloid leukemia blast crisis resistant to imatinib.
Junmei Z; Fengkuan Y; Yongping S; Baijun F; Yuzhang L; Lina L; Qinglan Z
Springerplus; 2015; 4():170. PubMed ID: 25897414
[TBL] [Abstract][Full Text] [Related]
13. A newborn with teratogenic effect of imatinib mesylate: a very rare case report.
Jain N; Sharma D; Agrawal R; Jain A
Med Princ Pract; 2015; 24(3):291-3. PubMed ID: 25896670
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
[TBL] [Abstract][Full Text] [Related]
15. Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology.
Dhillon S
Target Oncol; 2015 Jun; 10(2):303-10. PubMed ID: 25894578
[TBL] [Abstract][Full Text] [Related]
16. Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells.
Majercikova Z; Dibdiakova K; Gala M; Horvath D; Murin R; Zoldak G; Hatok J
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142793
[TBL] [Abstract][Full Text] [Related]
17. HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
[TBL] [Abstract][Full Text] [Related]
18. PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression.
Deng S; Leong HC; Datta A; Gopal V; Kumar AP; Yap CT
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406424
[TBL] [Abstract][Full Text] [Related]
19. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma.
Cai Y; Fu Y; Liu C; Wang X; You P; Li X; Song Y; Mu X; Fang T; Yang Y; Gu Y; Zhang H; He Z
Cell Death Dis; 2022 Feb; 13(2):176. PubMed ID: 35210426
[TBL] [Abstract][Full Text] [Related]
20. Stathmin dynamics modulate the activity of eribulin in breast cancer cells.
Yoshie M; Ishida A; Ohashi H; Nakachi N; Azumi M; Tamura K
Pharmacol Res Perspect; 2021 Aug; 9(4):e00786. PubMed ID: 34176226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
